Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: Involvement of HMGB1 in anti-DNA antibody-induced renal injury

Immunology Letters

Volumn 121, Issue 1, 2008, Pages 61-73

  Qing, Xiaoping ^a   Pitashny, Milena ^a   Thomas, David B ^b   Barrat, Franck J ^c   Hogarth, Mark P ^d   Putterman, Chaim ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c Dynavax Technologies Corporation   (United States)

^d AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Autoantibodies; Inflammation; Systemic lupus erythematosus

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DNA ANTIBODY; FC RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KIDNEY INJURY; LIGAND BINDING; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANIMALS; ANTIBODIES, ANTINUCLEAR; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MESANGIAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; MITOGEN-ACTIVATED PROTEIN KINASES; MYELOID DIFFERENTIATION FACTOR 88; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 54049128417     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.08.007     Document Type: Article

References (62)

1. Foster M.H., Cizman B., and Madaio M.P. Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest 69 (1993) 494-507
2. Hahn B.H. Antibodies to DNA. N Engl J Med 338 (1998) 1359-1368
3. Liang Z., Xie C., Chen C., Kreska D., Hsu K., Li L., et al. Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J Exp Med 199 (2004) 381-398
4. Clynes R., Dumitru C., and Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 (1998) 1052-1054
5. Fu Y., Xie C., Chen J., Zhu J., Zhou H., Thomas J., et al. Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1/TNF-alpha production. J Immunol 176 (2006) 632-639
6. Kaneko Y., Nimmerjahn F., Madaio M.P., and Ravetch J.V. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 203 (2006) 789-797
7. Matsumoto K., Watanabe N., Akikusa B., Kurasawa K., Matsumura R., Saito Y., et al. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Arthritis Rheum 48 (2003) 486-494
8. Tarzi R.M., Davies K.A., Robson M.G., Fossati-Jimack L., Saito T., Walport M.J., et al. Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells. Kidney Int 62 (2002) 2087-2096
9. Barrat F.J., Meeker T., Gregorio J., Chan J.H., Uematsu S., Akira S., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202 (2005) 1131-1139
10. Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R.A., Mamula M.J., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 202 (2005) 1171-1177
11. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
12. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., and Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312 (2006) 1669-1672
13. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 103 (2006) 9970-9975
14. Brown H.J., Lock H.R., Sacks S.H., and Robson M.G. TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol 177 (2006) 1925-1931
15. Rifkin I.R., Leadbetter E.A., Busconi L., Viglianti G., and Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204 (2005) 27-42
16. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298 (2002) 1025-1029
17. Kariko K., Ni H., Capodici J., Lamphier M., and Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279 (2004) 12542-12550
18. Smiley S.T., King J.A., and Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167 (2001) 2887-2894
19. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279 (2004) 7370-7377
20. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.Y., Strassheim D., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290 (2006) C917-C924
21. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
22. Wang H., Vishnubhakat J.M., Bloom O., Zhang M., Ombrellino M., Sama A., et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126 (1999) 389-392
23. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270 (1995) 25752-25761
24. Kokkola R., Andersson A., Mullins G., Ostberg T., Treutiger C.J., Arnold B., et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 61 (2005) 1-9
25. Abraham E., Arcaroli J., Carmody A., Wang H., and Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J Immunol 165 (2000) 2950-2954
26. Ek M., Popovic K., Harris H.E., Naucler C.S., and Wahren-Herlenius M. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 54 (2006) 2289-2294
27. Popovic K., Ek M., Espinosa A., Padyukov L., Harris H.E., Wahren-Herlenius M., et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 52 (2005) 3639-3645
28. Barkauskaite V., Ek M., Popovic K., Harris H.E., Wahren-Herlenius M., and Nyberg F. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus 16 (2007) 794-802
29. Ayer L.M., Senecal J.L., Martin L., Dixon G.H., and Fritzler M.J. Antibodies to high mobility group proteins in systemic sclerosis. J Rheumatol 21 (1994) 2071-2075
30. Bustin M., Reisch J., Einck L., and Klippel J.H. Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases. Science 215 (1982) 1245-1247
31. Santoro P., De Andrea M., Migliaretti G., Trapani C., Landolfo S., and Gariglio M. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases. J Rheumatol 29 (2002) 90-93
32. Wittemann B., Neuer G., Michels H., Truckenbrodt H., and Bautz F.A. Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 33 (1990) 1378-1383
33. Qing X., Zavadil J., Crosby M.B., Hogarth M.P., Hahn B.H., Mohan C., et al. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 54 (2006) 2198-2210
34. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
35. Deocharan B., Qing X., Lichauco J., and Putterman C. Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 168 (2002) 3072-3078
36. Mason L.J., Ravirajan C.T., Rahman A., Putterman C., and Isenberg D.A. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?. Arthritis Rheum 50 (2004) 866-870
37. Mostoslavsky G., Fischel R., Yachimovich N., Yarkoni Y., Rosenmann E., Monestier M., et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 31 (2001) 1221-1227
38. Renaudineau Y., Croquefer S., Jousse S., Renaudineau E., Devauchelle V., Gueguen P., et al. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum 54 (2006) 2523-2532
39. Zhao Z., Weinstein E., Tuzova M., Davidson A., Mundel P., Marambio P., et al. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum 52 (2005) 522-530
40. Zhao Z., Deocharan B., Scherer P.E., Ozelius L.J., and Putterman C. Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin. J Immunol 176 (2006) 7704-7714
41. Deocharan B., Zhou Z., Antar K., Siconolfi-Baez L., Angeletti R.H., Hardin J., et al. Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J Immunol 179 (2007) 1313-1321
42. Emlen W., Ansari R., and Burdick G. DNA-anti-DNA immune complexes. Antibody protection of a discrete DNA fragment from DNase digestion in vitro. J Clin Invest 74 (1984) 185-190
43. Shuster A.M., Gololobov G.V., Kvashuk O.A., Bogomolova A.E., Smirnov I.V., and Gabibov A.G. DNA hydrolyzing autoantibodies. Science 256 (1992) 665-667
44. Takeuchi O., Kaufmann A., Grote K., Kawai T., Hoshino K., Morr M., et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 164 (2000) 554-557
45. Li Q., Xie C., Mackay M., Aranow C., Putterman C., and Mohan C. Glomerular proteome assays: a novel approach to study glomerular-reactive autoantibodies in lupus. J Clin Invest 115 (2005) 3428-3439
46. Harley J.B., Kelly J.A., and Kaufman K.M. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 28 (2006) 119-130
47. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6 (2006) 823-835
48. Satta N., Dunoyer-Geindre S., Reber G., Fish R.J., Boehlen F., Kruithof E.K., et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 109 (2006) 1507-1514
49. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192 (2000) 565-570
50. DeMarco R.A., Fink M.P., and Lotze M.T. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1. Mol Immunol 42 (2005) 433-444
51. Jaulmes A., Thierry S., Janvier B., Raymondjean M., and Marechal V. Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. FASEB J 20 (2006) 1727-1729
52. Yu M., Wang H., Ding A., Golenbock D.T., Latz E., Czura C.J., et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26 (2006) 174-179
53. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5 (2005) 331-342
54. Ulloa L., and Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 17 (2006) 189-201
55. Urbonaviciute V., Furnrohr B.G., Weber C., Haslbeck M., Wilhelm S., Herrmann M., et al. Factors masking HMGB1 in human serum and plasma. J Leukoc Biol 81 (2007) 67-74
56. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8 (2007) 487-496
57. Ohashi K., Burkart V., Flohe S., and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164 (2000) 558-561
58. Vabulas R.M., Ahmad-Nejad P., Costa C., Miethke T., Kirschning C.J., Hacker H., et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276 (2001) 31332-31339
59. Yokota S., Minota S., and Fujii N. Anti-HSP auto-antibodies enhance HSP-induced pro-inflammatory cytokine production in human monocytic cells via Toll-like receptors. Int Immunol 18 (2006) 573-580
60. Liu J., Karypis G., Hippen K.L., Vegoe A.L., Ruiz P., Gilkeson G.S., et al. Genomic view of systemic autoimmunity in MRL/lpr mice. Genes Immun 7 (2006) 156-168
61. Ka S.M., Cheng C.W., Shui H.A., Wu W.M., Chang D.M., Lin Y.C., et al. Mesangial cells of lupus-prone mice are sensitive to chemokine production. Arthritis Res Ther 9 (2007) R67
62. Liu B., Yang Y., Dai J., Medzhitov R., Freudenberg M.A., Zhang P.L., et al. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol 177 (2006) 6880-6888